chuminhua2019-01-03 23:08
$Ohr制药(OHRP)$
12/3,NeuBase Therapeutics通过反向收购Ohr Pharmaceutical,在纳斯达克上市。NeuBase的模块化反义肽核酸(PNA)平台PATrOL用于改善基因沉默疗法。网页链接查看全文
$Ohr制药(OHRP)$ DEF 14A - Other definitive proxy statements Filed: 2018-12-18 AccNo: 0001387131-18-006826 Size: 251 KB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ DEF 14A - Other definitive proxy statements Filed: 2018-12-18 AccNo: 0001387131-18-006826 Size: 251 KB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ PRE 14A - Other preliminary proxy statements Filed: 2018-12-07 AccNo: 0001387131-18-006691 Size: 251 KB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-10-04 AccNo: 0001387131-18-005225 Size: 28 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ DEF 14A - Other definitive proxy statements Filed: 2018-09-07 AccNo: 0001387131-18-004559 Size: 566 KB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-08-29 AccNo: 0001387131-18-004298 Size: 24 KBItem 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11Item 8.01: Other Events 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-08-23 AccNo: 0001387131-18-004183 Size: 19 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-14 AccNo: 0001387131-18-004016 Size: 1 MB 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-08-14 AccNo: 0001387131-18-004003 Size: 40 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Ohr Pharmaceuticals, Inc.(OHRP)$ 8-K - Current report Filed: 2018-08-14 AccNo: 0001387131-18-004003 Size: 40 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接